WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Mets Brain Tumors efficacy endpoints v3.1, Target lesion evaluated by Quantitative assessment, Time To Salvage Therapy In the Brain measured by Date of Salvage Therapy, MRI has types - With contrast - Without contrast - FLAIR, Target lesion evaluated by Quantitative assessment, Sum of the product of all lesions includes Total area of each leasion, Organ specific lesion ID includes - Supratentorial: hemispheric (L, R) - Infratentorial: brain stem cerebellum, Lung has histology - NSCLC - SCLC - other, Progression free survival (PFS) has subtypes Extracranial, Sum of longest diameters (SLD) has component Short axis for target lymph nodes, Lesion classified as Enhancing, Measurable lesions has subtype Non-target lesion, Non-target lesion evaluated by Qualitative Assessment, Sum of the product of all lesions includes Total area of each leasion, Enhancing classified as Measurable lesions, Tumor Response is assessed with CT, Regional includes Convection enhanced delivery, Existing lesion identified by Anatomical region, Lesion classified as Existing lesion, METASTATIC BRAIN TUMORS EFFICACY ENDPOINTS include Overall Survival (OS), New lesion identified by Anatomical region